UK markets close in 7 hours 26 minutes

Biomerica, Inc. (BMRA)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.7220-0.0027 (-0.37%)
At close: 04:00PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 12.11M
Enterprise value 7.65M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)2.23
Price/book (mrq)1.55
Enterprise value/revenue 1.42
Enterprise value/EBITDA -1.21

Trading information

Stock price history

Beta (5Y monthly) -1.04
52-week change 3-41.94%
S&P500 52-week change 325.01%
52-week high 32.1300
52-week low 30.7000
50-day moving average 30.9752
200-day moving average 31.0396

Share statistics

Avg vol (3-month) 357.99k
Avg vol (10-day) 380.02k
Shares outstanding 516.82M
Implied shares outstanding 616.82M
Float 815.59M
% held by insiders 17.30%
% held by institutions 126.73%
Shares short (28 Mar 2024) 466.5k
Short ratio (28 Mar 2024) 41.55
Short % of float (28 Mar 2024) 40.43%
Short % of shares outstanding (28 Mar 2024) 40.40%
Shares short (prior month 29 Feb 2024) 4133.45k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:2
Last split date 314 Nov 1994

Financial highlights

Fiscal year

Fiscal year ends 31 May 2023
Most-recent quarter (mrq)29 Feb 2024

Profitability

Profit margin -117.42%
Operating margin (ttm)-196.66%

Management effectiveness

Return on assets (ttm)-43.02%
Return on equity (ttm)-92.05%

Income statement

Revenue (ttm)5.41M
Revenue per share (ttm)0.32
Quarterly revenue growth (yoy)-8.50%
Gross profit (ttm)N/A
EBITDA -6.31M
Net income avi to common (ttm)-6.35M
Diluted EPS (ttm)-0.3700
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)5.32M
Total cash per share (mrq)0.32
Total debt (mrq)862k
Total debt/equity (mrq)11.04%
Current ratio (mrq)4.44
Book value per share (mrq)0.46

Cash flow statement

Operating cash flow (ttm)-5.28M
Levered free cash flow (ttm)-2.69M